Literature DB >> 33519823

A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults.

Montse Jiménez1, Lucía Pastor1,2,3, Victor Urrea1, María Luisa Rodríguez de la Concepción1, Erica Parker4, Laura Fuente-Soro2,3, Chenjerai Jairoce3, Inacio Mandomando3, Jorge Carrillo1, Denise Naniche2,3, Julià Blanco1,5.   

Abstract

Primary HIV infection (PHI) and subsequent chronic infection alter B-cell compartment. However, longitudinal analysis defining the dynamics of B-cell alterations are still limited. We longitudinally studied B-cell subsets in individuals followed for 1 year after PHI (n = 40). Treated and untreated chronic HIV infected (n = 56) and HIV-uninfected individuals (n = 58) were recruited as reference groups at the Manhiça District in Mozambique. B cells were analyzed by multicolor flow-cytometry. Anti-HIV humoral response and plasma cytokines were assessed by ELISA or Luminex-based technology. A generalized activation of B cells induced by HIV occurs early after infection and is characterized by increases in Activated and Tissue-like memory cells, decreases in IgM-IgD- (switched) and IgM-only B cells. These alterations remain mostly stable until chronic infection and are reverted in part by ART. In contrast, other parameters followed particular dynamics: PD-1 expression in memory cells decreases progressively during the first year of infection, Transitional B cells expand at month 3-4 after infection, and Marginal zone-like B cells show a late depletion. Plasmablasts expand 2 months after infection linked to plasma viral load and anti-p24 IgG3 responses. Most of well-defined changes induced by HIV in B-cell activation and memory subsets are readily observed after PHI, lasting until ART initiation. However, subsequent changes occur after sustained viral infection. These data indicate that HIV infection impacts B cells in several waves over time, and highlight that early treatment would result in beneficial effects on the B-cell compartment.
Copyright © 2021 Jiménez, Pastor, Urrea, Rodríguez de la Concepción, Parker, Fuente-Soro, Jairoce, Mandomando, Carrillo, Naniche and Blanco.

Entities:  

Keywords:  B-cell activation; PD-1; marginal zone (MZ) B cell; plasmablasts; transitional B cell

Year:  2021        PMID: 33519823      PMCID: PMC7844141          DOI: 10.3389/fimmu.2020.614319

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  41 in total

Review 1.  The dynamics of CD4+ T-cell depletion in HIV disease.

Authors:  J M McCune
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.

Authors:  Nicole L Yates; Judith T Lucas; Tracy L Nolen; Nathan A Vandergrift; Kelly A Soderberg; Kelly E Seaton; Thomas N Denny; Barton F Haynes; Myron S Cohen; Georgia D Tomaras
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

3.  B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.

Authors:  Saikat Boliar; Megan K Murphy; T Cameron Tran; Diane G Carnathan; Wendy S Armstrong; Guido Silvestri; Cynthia A Derdeyn
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Authors:  Merlin L Robb; Leigh A Eller; Hannah Kibuuka; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Eugene Kroon; Fred K Sawe; Samuel Sinei; Somchai Sriplienchan; Linda L Jagodzinski; Jennifer Malia; Mark Manak; Mark S de Souza; Sodsai Tovanabutra; Eric Sanders-Buell; Morgane Rolland; Julie Dorsey-Spitz; Michael A Eller; Mark Milazzo; Qun Li; Andrew Lewandowski; Hao Wu; Edith Swann; Robert J O'Connell; Sheila Peel; Peter Dawson; Jerome H Kim; Nelson L Michael
Journal:  N Engl J Med       Date:  2016-05-18       Impact factor: 91.245

5.  Memory B cell dysregulation in HIV-1-infected individuals.

Authors:  Jorge Carrillo; Eugènia Negredo; Jordi Puig; Luis Manuel Molinos-Albert; Maria Luisa Rodríguez de la Concepción; Marta Curriu; Marta Massanella; Jordi Navarro; Manel Crespo; Ester Viñets; Fuensanta Millá; Bonaventura Clotet; Julià Blanco
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

Review 6.  Transitional B cells: step by step towards immune competence.

Authors:  James B Chung; Michael Silverman; John G Monroe
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

7.  Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.

Authors:  Simone Pensieroso; Alberto Cagigi; Paolo Palma; Anna Nilsson; Claudia Capponi; Elio Freda; Stefania Bernardi; Rigmor Thorstensson; Francesca Chiodi; Paolo Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

Review 8.  Aging in HIV-Infected Subjects: A New Scenario and a New View.

Authors:  Eugenia Negredo; David Back; José-Ramón Blanco; Julià Blanco; Kristine M Erlandson; Maite Garolera; Giovanni Guaraldi; Patrick Mallon; José Moltó; José Antonio Serra; Bonaventura Clotet
Journal:  Biomed Res Int       Date:  2017-12-21       Impact factor: 3.411

9.  Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells.

Authors:  Thomas Liechti; Claus Kadelka; Dominique L Braun; Herbert Kuster; Jürg Böni; Melissa Robbiani; Huldrych F Günthard; Alexandra Trkola
Journal:  J Exp Med       Date:  2019-06-20       Impact factor: 14.307

10.  Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Authors:  Sylvie Amu; Gitit Lavy-Shahaf; Alberto Cagigi; Bo Hejdeman; Silvia Nozza; Lucia Lopalco; Ramit Mehr; Francesca Chiodi
Journal:  Retrovirology       Date:  2014-09-11       Impact factor: 4.602

View more
  1 in total

1.  The protective role of daidzein in intestinal health of turbot (Scophthalmus maximus L.) fed soybean meal-based diets.

Authors:  Guijuan Yu; Yang Liu; Weihao Ou; Jihong Dai; Qinghui Ai; Wenbing Zhang; Kangsen Mai; Yanjiao Zhang
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.